knowledge -WSS

knowledge

author：knowledge 2025-09-30 00:36:16 - browse：55163

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Advisers to the Food and Drug Administration voted 11-0 on Monday to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly — ruling that the treatment’s ability to slow the cognitive decline in patients outweighed its safety risks.

The unanimous outcome of the daylong advisory panel was the best-case scenario for Lilly, making it likely that the FDA will approve the drug, called donanemab, for a broad population of people diagnosed with mild cognitive impairment due to Alzheimer’s. A decision is expected later this year.

“The benefits outweigh the risks, as long as the risks are being monitored,” said Kathleen Poston, a neurologist at Stanford University and a member of the advisory panel.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： CDC wastewater surveillance dashboard to track bird flu hotspots

WSS

H5N1 communication has been strictly for the birds

H5N1 communication has been strictly for the birds

Louisiana bill approved classifying abortion pills as controlled substances

Congress: Prevent baby formula shortages by passing a new bill

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

The high cost of giving birth even with insurance

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Hepatitis C has a cure — but many Americans still lack access to it

Why some fertility treatments produce more boy babies

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

After affirmative action ruling, medical educators look to 'holistic review'

H5N1 bird flu: what we're starting to learn about infection in cows

After affirmative action ruling, medical educators look to 'holistic review'

H5N1 communication has been strictly for the birds

Wikipedia

Use wet bulb globe temperature, not heat index, to protect workers

Beyond aggravation: Constipation is an American epidemic

Study: AI not yet building 'n

What nurses really want: sufficient staffing for patient care

Study: Adult vaccinations pay for themselves in societal benefits

Hospitals need to get ahead of regulations on climate change

explore

hotspot

Wikipedia

focus